News for Phreesia, Inc. (PHR)

Phreesia posted strong 1Q26 results with rising profitability, better client monetization, and a new buyback program. Find out why PHR stock is a buy.

On May 29, 2025, Truist Securities maintained its

On May 29, 2025, Canaccord Genuity analyst Richard Close maintained a Buy rating on Phreesia (PHR) while adjusting the price target. The price target was lowere

Truist has adjusted its price target for Phreesia (PHR), raising it from $34 to $35 while maintaining a Buy rating on the stock. This decision follows Phreesia'

Operator: Good morning, ladies and gentlemen. And welcome to the Phreesia First Quarter Fiscal 2026 Earnings Conference Call. At this time, all participants are in a listen-only mode.

Canaccord has adjusted its price target for Phreesia (PHR), reducing it from $35 to $34, while maintaining a Buy rating on the stock. Despite the recent dip in

Revenue: $115.9 million, an increase of 15% year over year.Average Healthcare Services Clients: 4,411, an increase of 70 from the prior quarter and 346 from th

Phreesia Inc demonstrates robust revenue growth with a significant year-over-year increase.Despite growing revenues, the company faces challenges with operatin

May 28, 2025 / 12:30PM GMTOperator Good morning, ladies and gentlemen, and welcome to the Phreesia first-quarter fiscal 2026 earnings conference call. At this t

The headline numbers for Phreesia (PHR) give insight into how the company performed in the quarter ended April 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Phreesia, Inc. (NYSE: PHR) (”œPhreesia”) today announced that it will now release its fiscal first quarter 2026 financial results prior to the open of marke

Significant Reduction in Phreesia Holdings On March 31, 2025, Brown Advisory Inc executed a notable reduction in its holdings of Phreesia Inc, decreasing its po

Summary Phreesia Inc (PHR), a leader in patient activation solutions, has announced that it will release its fiscal first quarter 2026 financial results after m

KeyBanc has adjusted its price target for Phreesia (PHR), reducing it to $28 from the previous $30, yet maintaining an Overweight rating on the stock. As the co

DA Davidson has adjusted its price target for Phreesia (PHR), reducing it from $36 to $34, while maintaining a Buy rating on its shares. This change is part of

The consensus price target hints at a 28% upside potential for Phreesia (PHR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Shares of Phreesia Inc (PHR) fell 0.54% in mid-day trading on Mar 22. The stock reached an intraday low of $26.92, before recovering slightly to $27.46, dow

Shares of Phreesia Inc (PHR) surged 2.35% in mid-day trading on Mar 19. The stock reached an intraday high of $27.98, before settling at $27.91, up from its

Phreesia remains resilient, maintaining guidance and showing strong financial performance. Find out why I remain bullish on PHR stock.